Pandemic Influenza Vaccine H5N1 Baxter AG

WithdrawnHuman

Details

EMA number	EMEA/H/C/001200
ATC code	J07BB01
Authorisation	16 October 2009
Withdrawn	11 September 2023
Revision	8

EMA page

Therapeutic indication

Prophylaxis of influenza in an officially declared pandemic situation. Pandemic influenza vaccine should be used in accordance with official guidance.

MeSH: Influenza, Human;Immunization;Disease Outbreaks

Group: Vaccines

Active substances

influenza vaccine (whole virion, inactivated) containing antigen of: A/Vietnam/1203/2004 (H5N1)

Marketing Authorisation Holder

Resilience Biomanufacturing Ireland Limited

MAH

Timeline

Filter by authority:

Pandemic Influenza Vaccine H5N1 Baxter AG withdrawn

11 Sept 2023

withdrawnregulatory

Pandemic Influenza Vaccine H5N1 Baxter AG authorised

16 Oct 2009

authorisedregulatory